Drawing for JOYNTRUS

USPTO serial 79216266

JOYNTRUS

Reviewed by CopyMark Law Group

Reg. 5377511Status 404
Filing date
Status date
Registration date
Jan 16, 2018
Examiner
MAHONEY, PAULA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JOYNTRUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treatment of autoimmune diseases; pharmaceutical preparations for treatment of inflammatory diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis; pharmaceutical preparations for prevention of autoimmune diseases; pharmaceutical preparations for prevention of inflammatory diseases; pharmaceutical preparations for prevention of cancer; pharmaceutical preparations for prevention of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitisSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 16, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Aug 2, 2024C71TCANCELLED SECTION 71
Apr 19, 2018GPNXNOTIFICATION PROCESSED BY IB
Feb 26, 2018XXSSGENERIC MADRID TRANSACTION SENT TO IB
Feb 26, 2018XXCRGENERIC MADRID TRANSACTION CREATED
Feb 15, 2018GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 16, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2017NPUBNOTICE OF PUBLICATION
Sep 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2017DOCKASSIGNED TO EXAMINER
Sep 19, 2017MAFRAPPLICATION FILING RECEIPT MAILED
Sep 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 7, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance